1887

Abstract

In countries from which Crimean-Congo haemorrhagic fever (CCHF) is absent, the causative virus, CCHF virus (CCHFV), is classified as a hazard group 4 agent and handled in containment level (CL)-4. In contrast, most endemic countries out of necessity have had to perform diagnostic tests under biosafety level (BSL)-2 or -3 conditions. In particular, Turkey and several of the Balkan countries have safely processed more than 100 000 samples over many years in BSL-2 laboratories. It is therefore advocated that biosafety requirements for CCHF diagnostic procedures should be revised, to allow the tests required to be performed under enhanced BSL-2 conditions with appropriate biosafety laboratory equipment and personal protective equipment used according to standardized protocols in the countries affected. Downgrading of CCHFV research work from CL-4, BSL-4 to CL-3, BSL-3 should also be considered.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000610
2016-11-10
2020-04-01
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/11/2799.html?itemId=/content/journal/jgv/10.1099/jgv.0.000610&mimeType=html&fmt=ahah

References

  1. Akinci E., Öngürü P., Tanrici A., Uyar Y., Eren S., Bodur H.. 2009; Hemorrhagic fever seroprevalence in healthcare workers. FLORA the Journal of Infectious and Clinical Microbiology14:94–96
    [Google Scholar]
  2. Bente D. A., Forrester N. L., Watts D. M., McAuley A. J., Whitehouse C. A., Bray M.. 2013; Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res100:159–189 [CrossRef][PubMed]
    [Google Scholar]
  3. Bino S.. 2015; Current situation in CCHFV epidemiology in albania. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  4. Blow J. A., Dohm D. J., Negley D. L., Mores C. N.. 2004; Virus inactivation by nucleic acid extraction reagents. J Virol Methods119:195–198 [CrossRef][PubMed]
    [Google Scholar]
  5. Bodur H., Akinci E., Ascioglu S., Öngürü P., Uyar Y.. 2012; Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis18:640–642 [CrossRef][PubMed]
    [Google Scholar]
  6. Bulut C., Yilmaz G. R., Karako E., Onde U., Kocak Tufan Z., Demiroz A. P.. 2009; Risk of Crimean-Congo haemorrhagic fever among healthcare workers. Clin Microbiol Infect15:S654 Abstracts of the 19th ECCMID
    [Google Scholar]
  7. Burney M. I., Ghafoor A., Saleen M., Webb P. A., Casals J.. 1980; Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic-fever Congo virus in Pakistan, January 1976. Am J Trop Med Hyg29:941–947[PubMed]
    [Google Scholar]
  8. Burt F. J., Swanepoel R., Braack L. E.. 1993; Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol Infect111:547–557 [CrossRef][PubMed]
    [Google Scholar]
  9. Burt F. J.. 2015; Current situation in CCHFV epidemiology in South Africa. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  10. Celikbas A. K., Dokuzoğuz B., Baykam N., Gok S. E., Eroğlu M. N., Midilli K., Zeller H., Ergonul O.. 2014; Crimean-Congo hemorrhagic fever among health care workers, Turkey. Emerg Infect Dis20:477–479 [CrossRef][PubMed]
    [Google Scholar]
  11. Cevik M. A., Erbay A., Bodur H., Eren S. S., Akinci E., Sener K., Ongürü P., Kubar A.. 2007; Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis45:e96e100 [CrossRef][PubMed]
    [Google Scholar]
  12. Chen Z., Chang G., Zhang W., Chen Y., Wang X., Yang R., Liu C.. 2015; Mobile laboratory in Sierra Leone during outbreak of Ebola: practices and implications. Sci China Life Sci58:918–921 [CrossRef][PubMed]
    [Google Scholar]
  13. Chinikar S., Shayesteh M., Khakifirouz S., Jalali T., Rasi Varaie F. S., Rafigh M., Mostafavi E., Shah-Hosseini N.. 2013; Nosocomial infection of Crimean-Congo haemorrhagic fever in eastern Iran: case report. Travel Med Infect Dis11:252–255 [CrossRef][PubMed]
    [Google Scholar]
  14. Chinikar S.. 2015; Current Situation in CCHFV Epidemiology in Iran. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  15. Christova I.. 2015; Current situation in CCHFV epidemiology in bulgaria. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  16. Conger N. G., Paolino K. M., Osborn E. C., Rusnak J. M., Gunther S., Pool J., Rollin P. E., Allan P. F., Schmidt-Chanasit J. et al. 2015; Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerg Infect Dis21:23–31[CrossRef]
    [Google Scholar]
  17. Duh D., Saksida A., Petrovec M., Ahmeti S., Dedushaj I., Panning M., Drosten C., Avsic-Zupanc T.. 2007; Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis13:1769–1772 [CrossRef][PubMed]
    [Google Scholar]
  18. Elata A. T., Karsany M. S., Elageb R. M., Hussain M. A., Eltom K. H., Elbashir M. I., Aradaib I. E.. 2011; A nosocomial transmission of Crimean-Congo hemorrhagic fever to an attending physician in north Kordufan, Sudan. Virol J8:303[CrossRef]
    [Google Scholar]
  19. Elevli M., Ozkul A. A., Civilibal M., Midilli K., Gargili A., Duru N. S.. 2010; A newly identified Crimean-Congo hemorrhagic fever virus strain in Turkey. Int J Infect Dis14:E213E216 [CrossRef][PubMed]
    [Google Scholar]
  20. Ergonul O., Zeller H., Celikbas A., Dokuzoguz B.. 2007; The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. Int J Infect Dis11:48–51 [CrossRef][PubMed]
    [Google Scholar]
  21. Estrada-Peña A., Vatansever Z., Gargili A., Buzgan T.. 2007; An early warning system for Crimean-Congo haemorrhagic fever seasonality in Turkey based on remote sensing technology. Geospat Health2:127–135 [CrossRef][PubMed]
    [Google Scholar]
  22. Fajs L., Humolli I., Saksida A., Knap N., Jelovšek M., Korva M., Dedushaj I., Avšič-Županc T.. 2014; Prevalence of Crimean-Congo hemorrhagic fever virus in healthy population, livestock and ticks in Kosovo. PLoS One9:e110982 [CrossRef][PubMed]
    [Google Scholar]
  23. Faye O., Faye O., Soropogui B., Patel P., El Wahed A. A., Loucoubar C., Fall G., Kiory D., Magassouba N. et al. 2015; Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill20:44 [CrossRef]
    [Google Scholar]
  24. Fernandez-Garcia M. D., Negredo A., Papa A., Donoso-Mantke O., Niedrig M., Zeller H., Tenorio A., Franco L., Enivd M.. 2012; European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever. Euro Surveill2014:19
    [Google Scholar]
  25. Fisher-Hoch S. P., McCormick J. B., Swanepoel R., Van Middlekoop A., Harvey S., Kustner H. G.. 1992; Risk of human infections with Crimean-Congo hemorrhagic fever virus in a South African rural community. Am J Trop Med Hyg47:337–345[PubMed]
    [Google Scholar]
  26. Gaidamovich S. Y., Butenko A. M., Leschinskaya H. V.. 2000; Human laboratory acquired arbo-, arena-, and hantavirus infections. Appl Biosaf5:5–11 [CrossRef]
    [Google Scholar]
  27. Gozel M. G., Dokmetas I., Oztop A. Y., Engin A., Elaldi N., Bakir M.. 2013; Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus. Int J Infect Dis17:E1046E1050 [CrossRef][PubMed]
    [Google Scholar]
  28. Gozel M. G., Bakir M., Oztop A. Y., Engin A., Dokmetas I., Elaldi N.. 2014; Investigation of Crimean-Congo hemorrhagic fever virus transmission from patients to relatives: a prospective contact tracing study. Am J Trop Med Hyg90:160–162 [CrossRef][PubMed]
    [Google Scholar]
  29. Gunes T., Engin A., Poyraz O., Elaldi N., Kaya S., Dokmetas I., Bakir M., Cinar Z.. 2009; Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg Infect Dis15:461–464 [CrossRef][PubMed]
    [Google Scholar]
  30. Gürbüz Y., Sencan I., Oztürk B., Tütüncü E.. 2009; A case of nosocomial transmission of Crimean-Congo hemorrhagic fever from patient to patient. Int J Infect Dis13:e105e107 [CrossRef][PubMed]
    [Google Scholar]
  31. Harxhi A., Pilaca A., Delia Z., Pano K., Rezza G.. 2005; Crimean-Congo hemorrhagic fever: a case of nosocomial transmission. Infection33:295–296 [CrossRef][PubMed]
    [Google Scholar]
  32. Hasan Z., Mahmood F., Jamil B., Atkinson B., Mohammed M., Samreen A., Altaf L., Moatter T., Hewson R.. 2013; Crimean-Congo hemorrhagic fever nosocomial infection in a immunosuppressed patient, Pakistan: case report and virological investigation. J Med Virol85:501–504 [CrossRef][PubMed]
    [Google Scholar]
  33. Hoogstraal H.. 1979; The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol15:307–417 [CrossRef][PubMed]
    [Google Scholar]
  34. Humolli I. D. I.. 2015; Current situation in CCHFV epidemiology in kosovo. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  35. Ince Y., Yasa C., Metin M., Sonmez M., Meram E., Benkli B., Ergonul O.. 2014; Crimean-Congo hemorrhagic fever infections reported by ProMED. Int J Infect Dis26:44–46 [CrossRef][PubMed]
    [Google Scholar]
  36. Inglis T. J.. 2015; Adapting the mobile laboratory to the changing needs of the Ebola virus epidemic. J Med Microbiol64:587–591 [CrossRef][PubMed]
    [Google Scholar]
  37. Joubert J. R., King J. B., Rossouw D. J., Cooper R.. 1985; A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S Afr Med J68:722–728[PubMed]
    [Google Scholar]
  38. Karimov S. K., Kiryushchenko T. V., Reformatskaya A. F., Suleimenova G. S.. 1975; A case of a laboratory infection with the Crimean hemorrhagic fever virus. Zh Mikrobiol Epidemiol Immunobiol5:136–137
    [Google Scholar]
  39. Korukluoglu G.. 2015; Current situation in CCHFV epidemiology in Turkey. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  40. Kunchev A., Kojouharova M.. 2008; Probable cases of Crimean-Congo-haemorrhagic fever in Bulgaria: a preliminary report. Euro Surveill13:17
    [Google Scholar]
  41. Larichev V.. 2015; Current situation in CCHFV epidemiology in Russia. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  42. Leblebicioglu H., Sunbul M., Guner R., Bodur H., Bulut C., Duygu F., Elaldi N., Senturk G. C., Ozkurt Z. et al. 2016; Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect22:387 [CrossRef][PubMed]
    [Google Scholar]
  43. Lvov D. K.. 1994; Arboviral zoonoses of northern Eurasia (Eastern Europe and the Commonwealth of Independent States). In Handbook of Zoonoses , pp.237–260 Edited by Beran G. W.. Boca Rotan, Florida: CRC Press;
    [Google Scholar]
  44. Mardani M., Rahnavardi M., Rajaeinejad M., Naini K. H., Chinikar S., Pourmalek F., Rostami M., Shahri M. H.. 2007; Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg76:443–445[PubMed]
    [Google Scholar]
  45. Mardani M., Keshtkar-Jahromi M., Ataie B., Adibi P.. 2009; Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg81:675–678 [CrossRef][PubMed]
    [Google Scholar]
  46. Mertens M. V. Z., Farkas R., Donnet. F., Comtet L., Ben Mechlia M., Tordo N., Groschup H.. 2015; CCHFV – The first line of protection is understanding. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  47. Midilli K., Gargili A., Ergonul O., Elevli M., Ergin S., Turan N., Sengöz G., Ozturk R., Bakar M.. 2009; The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey. BMC Infect Dis9:90 [CrossRef][PubMed]
    [Google Scholar]
  48. Mitchell S. W., McCormick J. B.. 1984; Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol20:486–489[PubMed]
    [Google Scholar]
  49. Mourya D. T., Yadav P. D., Shete A., Majumdar T. D., Kanani A., Kapadia D., Chandra V., Kachhiapatel A. J., Joshi P. T. et al. 2014; Serosurvey of Crimean-Congo hemorrhagic fever virus in domestic animals, Gujarat, India, 2013. Vector Borne Zoonotic Dis14:690–692 [CrossRef][PubMed]
    [Google Scholar]
  50. Nabeth P., Cheikh D. O., Lo B., Faye O., Vall I. O. M., Niang M., Wague B., Diop D., Diallo M. et al. 2004; Crimean-Congo hemorrhagic fever, Mauritania. Emerg Infect Dis10:2143–2149 [CrossRef][PubMed]
    [Google Scholar]
  51. Naderi H. R., Sheybani F., Bojdi A., Khosravi N., Mostafavi I.. 2013; Fatal nosocomial spread of Crimean-Congo hemorrhagic fever with very short incubation period. Am J Trop Med Hyg88:469–471 [CrossRef][PubMed]
    [Google Scholar]
  52. Osterholm M. T., Moore K. A., Kelley N. S., Brosseau L. M., Wong G., Murphy F. A., Peters C. J., LeDuc J. W., Russell P. K. et al. 2015; Transmission of Ebola viruses: what we know and what we do not know. MBio6:e01154 [CrossRef]
    [Google Scholar]
  53. Ozkaya E., Dincer E., Carhan A., Uyar Y., Ertek M., Whitehouse C. A., Ozkul A.. 2010; Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: occurrence of local topotype. Virus Res149:64–70 [CrossRef][PubMed]
    [Google Scholar]
  54. Papa A., Bino S., Llagami A., Brahimaj B., Papadimitriou E., Pavlidou V., Velo E., Cahani G., Hajdini M. et al. 2001; Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis2002:603–606
    [Google Scholar]
  55. Papa A., Bozovi B., Pavlidou V., Papadimitriou E., Pelemis M., Antoniadis A.. 2002; Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis8:852–854 [CrossRef][PubMed]
    [Google Scholar]
  56. Papa A., Christova I., Papadimitriou E., Antoniadis A.. 2004; Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis10:1465–1467 [CrossRef][PubMed]
    [Google Scholar]
  57. Papa A., Chaligiannis I., Kontana N., Sourba T., Tsioka K., Tsatsaris A., Sotiraki S.. 2014; A novel AP92-like Crimean-Congo hemorrhagic fever virus strain, Greece. Ticks Tick Borne Dis5:590–593 [CrossRef][PubMed]
    [Google Scholar]
  58. Papadopoulos O., Koptopoulos G.. 1980; Crimean-Congo Hemorrhagic Fever (CCHF) in Greece: Isolation of the Virus From Rhipicephalus Bursa Ticks and a Preliminary Serological Survey Edited by Vesenjak-Hirjan J., Porterfield J.. Stuttgart: Gustav Fisher Verlag;
    [Google Scholar]
  59. ProMED-mail. 2009a; Crimean-Congo hem. fever – Kazakhstan: (SK). ProMED-mail 2009;15 Jul: 20090715.2529
  60. ProMED-mail. 2009b; Crimean-Congo hem. fever – Tajikistan: (TC). ProMED-mail 2009;15 Aug: 20090815.2898
  61. Pshenichnaya N. Y., Nenadskaya S. A.. 2015; Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int J Infect Dis33:120–122 [CrossRef][PubMed]
    [Google Scholar]
  62. Saijo M., Tang Q., Shimayi B., Han L., Zhang Y., Asiguma M., Tianshu D., Maeda A., Kurane I., Morikawa S.. 2004; Possible horizontal transmission of Crimean-Congo hemorrhagic fever virus from a mother to her child. Jpn J Infect Dis57:55–57[PubMed]
    [Google Scholar]
  63. Samudzi R. R., Leman P. A., Paweska J. T., Swanepoel R., Burt F. J.. 2012; Bacterial expression of Crimean-Congo hemorrhagic fever virus nucleoprotein and its evaluation as a diagnostic reagent in an indirect ELISA. J Virol Methods179:70–76 [CrossRef][PubMed]
    [Google Scholar]
  64. Service USDoHaHSPH 2009; Biosafety in Microbiological and Biomedical Laboratories, 5th edn. Washington: U.S. Government Printing Office;
    [Google Scholar]
  65. Shepherd A. J., Swanepoel R., Shepherd S. P., Leman P. A., Blackburn N. K., Hallett A. F.. 1985; A nosocomial outbreak of Crimean-Congo hemorrhagic-fever at Tygerberg Hospital. 5. Virological and serological observations. S Afr Med68:733–736
    [Google Scholar]
  66. Shepherd A. J., Swanepoel R., Leman P. A., Shepherd S. P.. 1987a; Field and laboratory investigation of Crimean-Congo haemorrhagic fever virus (Nairovirus, family Bunyaviridae) infection in birds. Trans R Soc Trop Med Hyg81:1004–1007 [CrossRef][PubMed]
    [Google Scholar]
  67. Shepherd A. J., Swanepoel R., Shepherd S. P., McGillivray G. M., Searle L. A.. 1987b; Antibody to Crimean-Congo hemorrhagic fever virus in wild mammals from southern Africa. Am J Trop Med Hyg36:133–142[PubMed]
    [Google Scholar]
  68. Smither S. J., Weller S. A., Phelps A., Eastaugh L., Ngugi S., O'Brien L. M., Steward J., Lonsdale S. G., Lever M. S.. 2015; Buffer AVL alone does not inactivate Ebola virus in a representative clinical sample type. J Clin Microbiol53:3148–3154 [CrossRef][PubMed]
    [Google Scholar]
  69. Suleiman M. N., Muscat-Baron J. M., Harries J. R., Satti A. G., Platt G. S., Bowen E. T., Simpson D. I.. 1980; Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the rashid hospital. Lancet2:939–941[PubMed][CrossRef]
    [Google Scholar]
  70. Swanepoel R., Shepherd A. J., Leman P. A., Shepherd S. P., McGillivray G. M., Erasmus M. J., Searle L. A., Gill D. E.. 1987; Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg36:120–132[PubMed]
    [Google Scholar]
  71. Tarantola A., Ergonul O., Tattevin P.. 2007; Estimates and Prevention of Crimean Congo Hemorrhagic Fever Risks for Health Care Workers Edited by Ergonul O., Whitehouse C.. Dordrecht, Netherlands: Springer;[CrossRef]
    [Google Scholar]
  72. Tezer H., Sucakli I. A., Sayli T. R., Celikel E., Yakut I., Kara A., Tunc B., Ergonul O.. 2010; Crimean-Congo hemorrhagic fever in children. J Clin Virol48:184–186 [CrossRef][PubMed]
    [Google Scholar]
  73. Tezer H., Tavil B., Sucakli I. A., Korukluoğlu G., Uyar Y., Dinçer E., Tunç B., Özkul A.. 2011; Concurrent Crimean-Congo hemorrhagic fever and visceral leishmaniasis in a Turkish girl. Vector Borne Zoonotic Dis11:743–745 [CrossRef][PubMed]
    [Google Scholar]
  74. Tuna N. K. O.. 2015; Current CCHFV transmission with contaminated mask: case report. In 1st International Conference on Crimean-Congo Hemorrhagic Fever 13–14 March 2015, Thessaloniki:
    [Google Scholar]
  75. Uyar Y., Carhan A., Albayrak N., Altaş A. B.. 2010; Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey. Mikrobiyol Bul44:57–64[PubMed]
    [Google Scholar]
  76. Vandewal B. W., Joubert J. R., Vaneeden P. J., King J. B.. 1985; A nosocomial outbreak of Crimean-Congo hemorrhagic-fever at Tygerberg Hospital. 4. Preventive and prophylactic measures. S Afr Med J68:729–732
    [Google Scholar]
  77. Vaneeden P. J., Joubert J. R., Vandewal B. W., King J. B., Dekock A., Groenewald J. H.. 1985a; A nosocomial outbreak of Crimean-Congo hemorrhagic-fever at Tygerberg Hospital. 1. Clinical features. S Afr Med J68:711–717
    [Google Scholar]
  78. Vaneeden P. J., Vaneeden S. F., Joubert J. R., King J. B., Vandewal B. W., Michell W. L.. 1985b; A nosocomial outbreak of Crimean-Congo hemorrhagic-fever at Tygerberg Hospital. 2. Management of patients. S Afr Med J68:718–721
    [Google Scholar]
  79. Vinner L., Fomsgaard A.. 2007; Inactivation of orthopoxvirus for diagnostic PCR analysis. J Virol Methods146:401–404 [CrossRef][PubMed]
    [Google Scholar]
  80. Wehrle P. F., Posch J., Richter K. H., Henderson D. A.. 1970; An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Organ43:669[PubMed]
    [Google Scholar]
  81. Weidmann M.. 2012; Learning From a History of Laboratory Accidents Edited by Weidmann M., EIschner M., Silman N., Butaye P.. Weinheim, Germany: Wiley Blackwell;
    [Google Scholar]
  82. Williams R. J., Al-Busaidy S., Mehta F. R., Maupin G. O., Wagoner K. D., Al-Awaidy S., Suleiman A. J., Khan A. S., Peters C. J., Ksiazek T. G.. 2000; Crimean-Congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Trop Med Int Health5:99–106 [CrossRef][PubMed]
    [Google Scholar]
  83. Wölfel R., Stoecker K., Fleischmann E., Gramsamer B., Wagner M., Molkenthin P., Di Caro A., Günther S., Ibrahim S. et al. 2015; Mobile diagnostics in outbreak response, not only for Ebola: a blueprint for a modular and robust field laboratory. Euro Surveill20:44 [CrossRef]
    [Google Scholar]
  84. World Health Organization 2004; Laboratory Biosafety Manual, 3rd edn. ISBN 92 4 154650 6 (LC/NLM classification: QY 25) WHO/CDS/CSR/LYO/2004.11
    [Google Scholar]
  85. Yadav P. D., Cherian S. S., Zawar D., Kokate P., Gunjikar R., Jadhav S., Mishra A. C., Mourya D. T.. 2013; Genetic characterization and molecular clock analyses of the Crimean-Congo hemorrhagic fever virus from human and ticks in India, 2010–2011. Infect Genet Evol14:223–231 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000610
Loading
/content/journal/jgv/10.1099/jgv.0.000610
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error